|Day Low/High||54.40 / 56.13|
|52 Wk Low/High||58.46 / 82.15|
Stocks finish week sharply lower on worries over global economic growth slowing after earlier surging on Fed's more accommodating stance.
We provide several investment ideas for those that have kept their powder dry.
NEW YORK, March 22, 2019 /PRNewswire/ -- Amarin Corporation plc (AMRN) Lifshitz & Miller announces investigation into possible securities laws violations in connection with allegations that Amarin administered an active agent to their placebo group during...
Jim discusses Alphabet's stadia gaming initiative, our annual contribution to charity, the importance of individual stocks, when to buy our semiconductor stocks, and much more!
We are encouraged with CVS Health's plans to fix what has hurt the company and we reiterate that the stock is still inexpensive.
While today's action isn't attractive, we were ripe for a little profit-taking.
Jim Cramer has a playbook for finding the stocks that can make money without the economy filling the sails.
HARTFORD, Conn., March 21, 2019 /PRNewswire/ -- Aetna, a CVS Health (NYSE:CVS) business, is offering resources to members who have been affected by floods in Illinois, Iowa, Kansas, Michigan, Nebraska, Ohio, South Dakota and Wisconsin.
Curaleaf says it signed a deal with CVS to begin selling hemp products at 800 stores in 10 states.
While the two companies seem very similar on the surface, CVS and Walgreens are different stocks for different types of investors.
Jim Cramer says there's a lot to like about this market, but he says we can't ignore that it's prone to trade-related woes.
I think sometimes the best way to parse the temperament is to go over the most obviously 'wrong' moves and address why they might not be wrong at all.
82 colleges and universities receive grants from CVS Health Foundation, American Cancer Society and Truth Initiative to help deliver a tobacco-free generation
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of CVS Health Corporation (NYSE: CVS) from May 21, 2015 through February 20, 2019, inclusive (the "Class Period").
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C.
A full replay of the call will be available shortly and an edited transcript of the call will be posted in the coming days.
Jim Cramer breaks down why investors should be careful about paying more for the same earnings estimate.
Jim discusses Bernstein's initiation of CVS with an Outperform rating, Apple's March 25th event but why they need to focus on healthcare, and more!
Bernstein initiates coverage of CVS with an outperform rating.
With all the unknowns surrounding Boeing it's way too early to take a position in the aircraft maker; the same is not true with CVS.
National security is job one. Cutting a nice deal with China that benefits both sides must come second.
This is hope, not fact -- don't pay more for the same old thing.
We view the commitment to price reductions to be a crucial one that will allow UNH to differentiate itself as the fight for lower healthcare costs heats up.
Jim discusses his view of yesterday's Apple upgrade, transparency around hospital bills, the insider buy activity at CVS, and answers club member questions!
We've seen the value at these levels, insiders are seeing it, and rest of the market should begin to see it too.
The market's reaction to the pharmacy giant's acquisition of Aetna is providing a rare opportunity to buy a quality company at a value price.
When markets move higher, it is no time to be complacent, rather it is a perfect time to check in on the portfolio.
Friday's bad employment number could have been a lot worse.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.